TY  - BOOK
AU  - Mühlbacher, Axel
AU  - Juhnke, Christin
AB  - The GKV-VSG introduced for the first time the benefit assessment of examination and treatment methods with medical devices of high classes and invasive character. In the future, the decision on reimbursement will depend on the documentation of benefits and harm. Basically, the benefit assessment can be divided into three phases: measuring the causal effects of an intervention, evaluating the measured effects and deciding on the reimbursement of an aggregate overall benefit. In order to meet the requirements, adaptive study designs, the multi-criteria decision analysis and the adaptive benefit assessment represent a future-proof concept for quick access for patients to innovative treatment methods with high quality and safety.
DO  - 10.32745/9783954664597
ID  - OAPEN ID: ONIX_20200617_9783954664597_41
KW  - assessment of benefit
KW  - study design
KW  - decision analysis
L1  - https://library.oapen.org/bitstream/id/830a8442-c1c1-4bf2-b707-55ddbe49a2b0/adaptive-nutzenbewertung-fur-untersuchungs-und-behandlungsmethoden-mit-medizinprodukten-hoher-klassen.pdf
LA  - German
LK  - http://library.oapen.org/handle/20.500.12657/39700
PB  - MWV Medizinisch Wissenschaftliche Verlagsgesellschaft
PP  - Berlin
PY  - 2016
TI  - Adaptive Nutzenbewertung für Untersuchungs- und Behandlungsmethoden mit Medizinprodukten hoher Klassen : Die Abwägung von Patientennutzen, Evidenz und Zugang
ER  - 
